BCM
ABBV icon

BBT Capital Management’s AbbVie ABBV Stock Holding History

BBT Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,751
Closed -$779K – 261
2013
Q4 		$779K Hold
14,751
– – 0.04% 248
2013
Q3 		$660K Sell
14,751
-1,046
-7% -$46.4K 0.03% 252
2013
Q2 		$653K Buy
+15,797
New +$691K 0.03% 239

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BBT Capital Management's ABBV Position: Q1 2014 in Review

BBT Capital Management sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 14,751 shares — an estimated $779K sold.

BBT Capital Management first reported a position in ABBV in Q2 2013 and held it in 3 quarters. The position peaked at $779K in Q4 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • BBT Capital Management reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
  • BBT Capital Management sold 14,751 AbbVie shares in Q1 2014, an estimated $779K.
  • BBT Capital Management first reported a position in AbbVie in Q2 2013 and held it in 3 quarters.
  • BBT Capital Management's AbbVie position peaked at $779K in Q4 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on BBT Capital Management's 13F filing for Q1 2014, filed 9 May 2014.